Stay updated on SGN-PDL1V in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the SGN-PDL1V in Advanced Solid Tumors Clinical Trial page.

Latest updates to the SGN-PDL1V in Advanced Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating an administrative update to the site’s content management system. This update does not change the study details presented on the page.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe study's location list expanded to 62 sites, adding Gustave Roussy Institute in Villejuif, France, and a Beijing, China site. Paris and Beijing addresses were updated to reflect new postal codes.SummaryDifference0.7%

- Check51 days agoChange DetectedThe page revision changed from v3.6.2 to v3.6.3. This update signals a newer version of the page and is a technical change without modifying study content.SummaryDifference0.0%

- Check59 days agoChange DetectedA new revision tag v3.6.2 was added and the older tag v3.6.0 was removed. This indicates a small version update with no changes to the study details or functionality.SummaryDifference0.0%

- Check73 days agoChange DetectedNew quick-access links were added to the study page to help users find joining, contacting, and reading information. The Intervention/Treatment label was standardized and the revision stamp updated to v3.6.0.SummaryDifference0.3%

- Check80 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new version of the ClinicalTrials.gov entry. This reflects an administrative update rather than a change to the study details or results.SummaryDifference0.0%

Stay in the know with updates to SGN-PDL1V in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SGN-PDL1V in Advanced Solid Tumors Clinical Trial page.